VIA Pharmaceuticals (VIA Pharmaceuticals) Earnings per Share (Diluted) : $-0.47 (TTM As of Dec. 2010)

VIA Pharmaceuticals Earnings per Share (Diluted) Chart

VIA Pharmaceuticals Annual Data
	Trend	Dec01	Dec02	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10
Earnings per Share (Diluted)		Get a 7-Day Free Trial					-19.81	-2.24	-1.03	-1.05	-0.47

VIA Pharmaceuticals Quarterly Data
	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10
Earnings per Share (Diluted)	Get a 7-Day Free Trial															-0.21	-0.14	-0.11	-0.10	-0.12

Competitive Comparison of VIA Pharmaceuticals's Earnings per Share (Diluted)

For the Biotechnology subindustry, VIA Pharmaceuticals's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

VIA Pharmaceuticals's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, VIA Pharmaceuticals's PE Ratio distribution charts can be found below:

* The bar in red indicates where VIA Pharmaceuticals's PE Ratio falls into.

VIA Pharmaceuticals Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

VIA Pharmaceuticals's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2010 is calculated as

VIA Pharmaceuticals's Earnings Per Share (Diluted) for the quarter that ended in Dec. 2010 is calculated as

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2010 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.

VIA Pharmaceuticals  (GREY:VIAP) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

VIA Pharmaceuticals Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of VIA Pharmaceuticals's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

VIA Pharmaceuticals (VIA Pharmaceuticals) Business Description